Capital Research Global Investors Portfolio holdings
Capital Research Global Investors (CRGI), a division of Capital Group established in 1931 and headquartered in Los Angeles, California, is a powerhouse in active investment management, overseeing hundreds of billions in assets with a focus on global equity portfolios. Known for its long-term, research-intensive approach, CRGI employs a unique multiple-portfolio-manager system to diversify risk and enhance returns, serving institutional clients, financial advisors, and individual investors through vehicles like the American Funds mutual fund family. The firm’s investment philosophy emphasizes fundamental analysis and a deep understanding of companies worldwide, aiming to identify growth opportunities over extended horizons. As part of Capital Group’s broader mission, CRGI has built a reputation for delivering consistent, value-driven results in the global investment landscape.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Lowe's Companies
LOW
|
+$2.49B |
| 2 |
Meta Platforms (Facebook)
META
|
+$2.37B |
| 3 |
Abbott
ABT
|
+$1.68B |
| 4 |
Microsoft
MSFT
|
+$1.49B |
| 5 |
Qualcomm
QCOM
|
+$1.47B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$2.59B |
| 2 |
Broadcom
AVGO
|
+$1.8B |
| 3 |
Apple
AAPL
|
+$1.77B |
| 4 |
Prudential Financial
PRU
|
+$1.26B |
| 5 |
Netflix
NFLX
|
+$969M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 19.63% |
| 2 | Technology | 13.7% |
| 3 | Communication Services | 12.98% |
| 4 | Consumer Discretionary | 12.24% |
| 5 | Financials | 10.25% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
176
East-West Bancorp
EWBC
$18.5B
| $337M | 0.1% |
5,387,455
-1,767,848
| -25% | -$116M |
|
177
Salesforce
CRM
$158B
| $335M | 0.1% |
2,882,182
-1,075,569
| -27% | -$124M |
|
178
Duke Energy
DUK
$96.3B
| $332M | 0.09% |
4,281,600
-217,951
| -5% | -$16.8M |
|
179
Extra Space Storage
EXR
$31B
| $331M | 0.09% |
3,788,000
-653,155
| -15% | -$54.9M |
|
|
RDS.A
180
DELISTED
Royal Dutch Shell PLC ADS Class A
RDS.A
| $331M | 0.09% |
5,184,617
-198,217
| -4% | -$13.1M |
|
181
Markel Group
MKL
$22.8B
| $328M | 0.09% |
280,344
+19
| +0% | +$21.4K |
|
|
CBPO
182
DELISTED
China Biologic Products Holdings, Inc.
CBPO
| $322M | 0.09% |
3,975,908
+694,944
| +21% | +$56.2M |
|
183
Molina Healthcare
MOH
$10.8B
| $322M | 0.09% |
+3,964,842
| New | +$319M |
|
184
Alcoa
AA
$13.5B
| $318M | 0.09% |
7,081,252
+3,809,830
| +116% | +$189M |
|
185
Yum! Brands
YUM
$41B
| $318M | 0.09% |
3,739,188
+317,568
| +9% | +$26M |
|
186
Texas Roadhouse
TXRH
$14.1B
| $314M | 0.09% |
5,439,942
+244
| +0% | +$14K |
|
|
NBIS
187
Nebius Group N.V.
NBIS
$65.8B
| $314M | 0.09% |
7,959,886
+7,562,886
| +1,905% | +$297M |
|
|
MLNX
188
DELISTED
Mellanox Technologies, Ltd.
MLNX
| $314M | 0.09% |
4,305,483
+493,550
| +13% | +$33.2M |
|
189
Citigroup
C
$231B
| $312M | 0.09% |
4,615,689
-156,762
| -3% | -$11.8M |
|
190
Zions Bancorporation
ZION
$10.5B
| $311M | 0.09% |
5,907,318
+355,407
| +6% | +$19.1M |
|
191
Visa
V
$671B
| $311M | 0.09% |
2,596,320
-2,720,392
| -51% | -$330M |
|
192
TJX Companies
TJX
$169B
| $307M | 0.09% |
7,535,290
+1,714,144
| +29% | +$67.8M |
|
193
Ultragenyx Pharmaceutical
RARE
$2.65B
| $302M | 0.09% |
5,914,447
+929,442
| +19% | +$46.8M |
|
194
Essent Group
ESNT
$6.14B
| $301M | 0.09% |
7,077,376
-40,000
| -0.6% | -$1.81M |
|
195
Adobe
ADBE
$103B
| $301M | 0.09% |
+1,392,461
| New | +$283M |
|
|
TWX
196
DELISTED
Time Warner Inc
TWX
| $300M | 0.09% |
3,168,260
-6,827,455
| -68% | -$643M |
|
197
Webster Financial
WBS
$12.8B
| $297M | 0.08% |
5,361,422
+165,422
| +3% | +$9.35M |
|
198
Danaher
DHR
$145B
| $295M | 0.08% |
3,401,543
+9,774
| +0.3% | +$855K |
|
199
IBM
IBM
$222B
| $292M | 0.08% |
1,990,691
-332,581
| -14% | -$50.3M |
|
200
Boston Scientific
BSX
$74.5B
| $289M | 0.08% |
10,579,076
+527
| +0% | +$14.3K |
|
Similar funds
Capital Research Global Investors's Q1 2018 Portfolio in Review
As of Q1 2018, Capital Research Global Investors held 467 positions worth $351B, up 3.1% from $341B the previous quarter. Its ten largest holdings account for 26% of the portfolio.
Capital Research Global Investors's Q1 2018 filing shows 35 new, 186 increased, 131 reduced and 24 closed positions. Its largest new stake was Qualcomm: 23,076,309 shares worth $1.28B. The largest sale was Amazon, an estimated $2.59B.
By sector, the portfolio is most concentrated in Healthcare at 20% of assets, up from 19% a quarter earlier, followed by Technology and Communication Services.
- Capital Research Global Investors's largest Q1 2018 buy was Qualcomm: 23,076,309 shares worth $1.28B.
- Capital Research Global Investors added most to Lowe's Companies in Q1 2018, an estimated $2.49B increase.
- Capital Research Global Investors's biggest Q1 2018 reduction was Amazon, cutting an estimated $2.59B.
- Capital Research Global Investors fully exited Agrium in Q1 2018, selling an estimated $549M.
- Capital Research Global Investors's ten largest holdings make up 26% of its $351B portfolio in Q1 2018.
- Capital Research Global Investors opened 35 new positions and closed 24 in Q1 2018.
- Capital Research Global Investors's portfolio value rose 3.1% quarter-over-quarter to $351B.
Based on Capital Research Global Investors's 13F filing for Q1 2018, filed 15 May 2018.